The KRAS/SOS1 binding Standard is intended for use with the KRAS WT/SOS1 and KRAS G12C/SOS1 binding kits.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
Feature | Specification |
---|---|
Application | Protein-Protein Interaction |
The KRAS/SOS1 binding Standard is intended for use with the KRAS WT/SOS1 and KRAS G12C/SOS1 binding kits.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
KRAS/SOS1 binding standard can be used as a standard to control assay reproducibility. KRAS/SOS1 binding d is intended for use with the KRAS WT/SOS1 and the KRAS G12C/SOS1 kits.
Application |
Protein-Protein Interaction
|
---|---|
Brand |
HTRF
|
Detection Modality |
HTRF
|
Product Group |
Standard
|
Shipping Conditions |
Shipped in Dry Ice
|
Target Class |
Binding Assay
|
Technology |
TR-FRET
|
Therapeutic Area |
Oncology & Inflammation
|
Unit Size |
1 Vial
|
The KRAS/SOS1 PPI assays include tagged human recombinant partners (KRAS WT or G12C and SOS1) and labelled anti-tag reagents for HTRF detection. Without any inhibitor, KRAS loaded with GTP binds to SOS1 , and the binding of each detection reagent to its tagged target generates an HTRF signal. In the presence of KRAS/SOS1 inhibitors or GTP competitors, the HTRF signal decreases.
The Human KRAS/SOS1 binding assay can be run in a 96- or 384-well low volume white plate (20 µL final). As described here, compounds or standards are dispensed directly into the assay plate. The pre-mixed GTP and human Tag1-KRAS protein is then added, together with the human Tag2-SOS1 protein, followed by the dispensing of the HTRF reagents, the anti-Tag2 antibody labeled with Terbium cryptate and the anti-Tag1 antibody labeled with XL665. The reagents labelled with HTRF fluorophores may be pre-mixed and added in a single dispensing step. No washing steps are needed. The protocol can be further miniaturized or upscaled by simply resizing each addition volume proportionally.
The KRAS/SOS1 binding standard inhibits the KRAS/SOS1 interaction for KRAS WT and KRAS G12C proteins in a correlated manner.
Are you looking for resources, click on the resource type to explore further.
Investigate the dynamics of Interactions
Kinetic values are of importance for characterizing protein-protein interactions...
This guide provides you an overview of HTRF applications in several therapeutic areas.
Your dream assay does not exist yet? Create it!
This guide will provide you with tools to help you develop your very own protein...
We are here to answer your questions.